Get started
Author

Shari Lau

Institution: Genentech
Observed institutions: Mayo Clinic, Genentech
ORCID: 0000-0001-7570-7455
Observed ORCID: 0000-0001-7570-7455
OpenAlex ID: A5058443702
CDK8 Maintains Tumor Dedifferentiation and Embryonic Stem Cell Pluripotency
2012 · Adam S. Adler, Mark L. McCleland, et al. · Cancer Research · 117
Intrinsic apoptosis shapes the tumor spectrum linked to inactivation of the deubiquitinase BAP1
2019 · Meng He, Mira S. Chaurushiya, et al. · Science · 105
Targeting the PI3K Pathway in the Brain—Efficacy of a PI3K Inhibitor Optimized to Cross the Blood–Brain Barrier
2012 · Laurent Salphati, Timothy P. Heffron, et al. · Clinical Cancer Research · 70
Brain Distribution and Efficacy of the Brain Penetrant PI3K Inhibitor GDC-0084 in Orthotopic Mouse Models of Human Glioblastoma
2016 · Laurent Salphati, Bruno Alicke, et al. · Drug Metabolism and Disposition · 52
Automated tumor immunophenotyping predicts clinical benefit from anti‐PD‐L1 immunotherapy
2024 · Xiao Li, Jeffrey Eastham, et al. · The Journal of Pathology · 13
PDF
Characterization of Tumor-immune Microenvironment by High-throughput Image Analysis of CD8 Immunohistochemistry Combined With Modified Masson’s Trichrome
2021 · Charles Havnar, Shari Lau, et al. · Journal of Histochemistry & Cytochemistry · 5
Loss of the autoimmune risk gene TREX1 reveals a convergence of mechanisms promoting immune tolerance loss and antitumor immunity
2026 · Junghyun Lim, Katherine Williams, et al. · Science Advances · 1
PDF
Immunohistochemistry-assisted deep learning for lineage identification in rat bone marrow from hematoxylin and eosin whole-slide images
2026 · Marco Tecilla, Edgar A. Rios Piedra, et al. · Veterinary Pathology
Supplementary Figure Legend from Targeting the PI3K Pathway in the Brain—Efficacy of a PI3K Inhibitor Optimized to Cross the Blood–Brain Barrier
2023 · Laurent Salphati, Timothy P. Heffron, et al.
PDF
Supplementary Table 1 from Targeting the PI3K Pathway in the Brain—Efficacy of a PI3K Inhibitor Optimized to Cross the Blood–Brain Barrier
2023 · Laurent Salphati, Timothy P. Heffron, et al.
PDF
Supplementary Figure 1 from Targeting the PI3K Pathway in the Brain—Efficacy of a PI3K Inhibitor Optimized to Cross the Blood–Brain Barrier
2023 · Laurent Salphati, Timothy P. Heffron, et al.
Supplementary Table 2 from Targeting the PI3K Pathway in the Brain—Efficacy of a PI3K Inhibitor Optimized to Cross the Blood–Brain Barrier
2023 · Laurent Salphati, Timothy P. Heffron, et al.
Supplementary Table 4 from Targeting the PI3K Pathway in the Brain—Efficacy of a PI3K Inhibitor Optimized to Cross the Blood–Brain Barrier
2023 · Laurent Salphati, Timothy P. Heffron, et al.
PDF
Supplementary Figure 2 from Targeting the PI3K Pathway in the Brain—Efficacy of a PI3K Inhibitor Optimized to Cross the Blood–Brain Barrier
2023 · Laurent Salphati, Timothy P. Heffron, et al.
PDF
Supplementary Table 3 from Targeting the PI3K Pathway in the Brain—Efficacy of a PI3K Inhibitor Optimized to Cross the Blood–Brain Barrier
2023 · Laurent Salphati, Timothy P. Heffron, et al.
PDF
Data from Targeting the PI3K Pathway in the Brain—Efficacy of a PI3K Inhibitor Optimized to Cross the Blood–Brain Barrier
2023 · Laurent Salphati, Timothy P. Heffron, et al.
Data from Targeting the PI3K Pathway in the Brain—Efficacy of a PI3K Inhibitor Optimized to Cross the Blood–Brain Barrier
2023 · Laurent Salphati, Timothy P. Heffron, et al.
Supplementary Table 3 from Targeting the PI3K Pathway in the Brain—Efficacy of a PI3K Inhibitor Optimized to Cross the Blood–Brain Barrier
2023 · Laurent Salphati, Timothy P. Heffron, et al.
Supplementary Table 2 from Targeting the PI3K Pathway in the Brain—Efficacy of a PI3K Inhibitor Optimized to Cross the Blood–Brain Barrier
2023 · Laurent Salphati, Timothy P. Heffron, et al.
PDF
Supplementary Figure 1 from Targeting the PI3K Pathway in the Brain—Efficacy of a PI3K Inhibitor Optimized to Cross the Blood–Brain Barrier
2023 · Laurent Salphati, Timothy P. Heffron, et al.
PDF
Supplementary Figure 2 from Targeting the PI3K Pathway in the Brain—Efficacy of a PI3K Inhibitor Optimized to Cross the Blood–Brain Barrier
2023 · Laurent Salphati, Timothy P. Heffron, et al.
Supplementary Figure Legend from Targeting the PI3K Pathway in the Brain—Efficacy of a PI3K Inhibitor Optimized to Cross the Blood–Brain Barrier
2023 · Laurent Salphati, Timothy P. Heffron, et al.
Supplementary Table 1 from Targeting the PI3K Pathway in the Brain—Efficacy of a PI3K Inhibitor Optimized to Cross the Blood–Brain Barrier
2023 · Laurent Salphati, Timothy P. Heffron, et al.
Supplementary Table 4 from Targeting the PI3K Pathway in the Brain—Efficacy of a PI3K Inhibitor Optimized to Cross the Blood–Brain Barrier
2023 · Laurent Salphati, Timothy P. Heffron, et al.
Supplementary Figures 1-12, Table 1 from CDK8 Maintains Tumor Dedifferentiation and Embryonic Stem Cell Pluripotency
2023 · Adam S. Adler, Mark L. McCleland, et al.
Works count: 30
Citation count: 363
H-index: 5
I10-index: 5
Year
Topic
Type